Hikma launches generic Vascepa

Hikma is introducing icosapent ethyl capsules in a dosage strength of 1 g.

The product is a generic of Amarin’s Vascepa.

The medication is indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.

Hikma noted that following an earlier than expected favorable court ruling, it has accelerated the launch of icosapent ethyl capsules “in order to quickly provide patients with access to this important medicine. Initially, Hikma will be releasing limited quantities to ensure a consistent supply for customers.  The company is working to scale up manufacturing and increase availability as soon as possible.”

“Hikma’s launch of this important medicine for U.S. patients and healthcare providers once again underscores our ability to put better health, within reach, every day for millions of people who rely on our medicines," said Brian Hoffmann, president of Hikma generics. "Today's launch demonstrates Hikma's ability to successfully challenge patents and launch complex products, bringing greater value to our customers and patients."